Author(s):
Renuka Pai, Jerome Jose Valiyaparambil, Parashuram Pai
Email(s):
pairenuka@yahoo.co.in
DOI:
10.52711/2454-2660.2025.00021 
Address:
Renuka Pai1, Jerome Jose Valiyaparambil2, Parashuram Pai3
1Consultant, Rangadore Memorial Hospital, Bangalore.
2Junior Resident, Studying for Post Graduation.
3Medical Intern, SDM Medical College, Dharwad, India.
*Corresponding Author
Published In:
Volume - 13,
Issue - 2,
Year - 2025
ABSTRACT:
The pathophysiology of oral mucositis is complex and its management is a challenge. Reduced immunity as in cancers, exposure to chemotherapy, exposure to radiotherapy in head and neck cancers are common causes. Oral mucositis is also seen as a manifestation of dermatological conditions affecting the muco-cutaneous structures of the body. We describe the effectiveness of “modified magic mouth wash” in a few such cases.
Cite this article:
Renuka Pai, Jerome Jose Valiyaparambil, Parashuram Pai. Effectiveness of Topical Intervention with Modified “Magic Mouth-Wash” in Treating the Pain of Oral Mucositis in Non-malignant Dermatological Conditions: An Observation Report of Three Case Profiles. International Journal of Nursing Education and Research. 2025;13(2):104-6. doi: 10.52711/2454-2660.2025.00021
Cite(Electronic):
Renuka Pai, Jerome Jose Valiyaparambil, Parashuram Pai. Effectiveness of Topical Intervention with Modified “Magic Mouth-Wash” in Treating the Pain of Oral Mucositis in Non-malignant Dermatological Conditions: An Observation Report of Three Case Profiles. International Journal of Nursing Education and Research. 2025;13(2):104-6. doi: 10.52711/2454-2660.2025.00021 Available on: https://ijneronline.com/AbstractView.aspx?PID=2025-13-2-9
REFERENCES:
1 Dalal A. Oral pemphigus vulgaris: A case-based rheumatological and immunological perspectives on a rare autoimmune mucocutaneous disease. IJRCI. 2021; 9(1): CS3
2 Rendon A, Schäkel K. Psoriasis Pathogenesis and Treatment- Review. Int. J. Mol. Sci. 2019; 20: 1475 doi:10.3390/ijms20061475
3 Schwartz RA, McDonough PH, Lee BW. Toxic epidermal necrolysis. Part I. Introduction, history, classifification, clinical features, systemic manifestations, etiology, and immunopathogenesis. J Am Acad Dermatol. 2013; 69(2).
4 https://oralcancerfoundation.org.Mucositis - Oral Cancer Foundation
5 Kusiak A, Jereczek-Fossa BA, Cichońska D, Alterio D. Oncological-Therapy Related Oral Mucositis as an Interdisciplinary Problem—Literature Review. Int J Environ Res Public Health. 2020; 17(7): 2464
6 Saunders DP, Rouleau T, Cheng K, Yarom N, KandwalA, Joy J, Kayhan KB, van de Wetering M, Brito-Dellan N, Kataoka T, C hiang K, Ranna V, Vaddi A, Epstein J, Lalla RV, Bossi P, Elad S. Systematic review of antimicrobials, mucosal coating agents, anesthetics, and analgesics for the management of oral mucositis in cancer patients and clinical practice guidelines. Support Care Cancer. 2020; 28(5): 2473-2484
7 Stout EI, McKessor A. Glycerin-Based Hydrogel for Infection Control. Advances in Wound Care. 2012. 1(1).